There is significant potential in decentralized models and digital health technology to expand diversity in clinical trials.
Monica Chmielewski and Alexandra Maulden
Advertisement
Articles by Monica Chmielewski and Alexandra Maulden
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ICON Selects Microsoft as Preferred Technology Partner to Scale Agentic AI Platform Across Clinical Trial Lifecycle
2
ACT Brief: Mixed FSP Strategy, DIA Meeting Trends, and Patient Voice in Oncology
3
ACT Brief: Real-Time Evidence Generation, Protocol Digitization, and Decentralized Trial Flexibility
4
2026 DIA Global Annual Meeting: Where Mixed Models Create the Most Value—and What It Takes to Make Them Work
5